Institute of Diabetes and Obesity (IDO)
The Institute of Diabetes and Obesity (IDO) studies the metabolic syndrome by means of systems biological and translational approaches. It seeks to discover new signaling pathways in order to develop innovative interdisciplinary approaches for the personalized prevention and treatment of obesity, diabetes and concomitant diseases. Here the methodological focus is on synergistic studies in cell-based systems, genetically modified mouse models and clinical intervention studies. To date, research results have not only led to the discovery of one of the most important control signals of appetite and metabolism (ghrelin), but also to the design of new drugs that are presently in clinical trials.
Director: Prof. Dr. Matthias Tschöp